Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients

E. A. Mittendorf*, G. T. Clifton, J. P. Holmes, E. Schneble, D. van Echo, S. Ponniah, G. E. Peoples

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

211 Scopus citations

Fingerprint

Dive into the research topics of 'Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences